PIK3CA and neoplasm: Additional deep sequencing confirmed that an activating PIK3CA (H1047R) mutation was present only in the primary tumor, not in the liver metastasis or cfDNA, indicating that either the mutation emerged after metastasis, or was not present in the subpopulation that seeded the metastasis.